Gonadotropin & Reproductive-Axis Peptides
Oxytocin
Last reviewed: 2026-11-19
Evidence status & limitations
Obstetric indications are supported by approved labeling; behavioral research does not establish other approved uses.
Regulatory status
FDA approval applies only to the named products and indications below. It does not approve every formulation or other use.
Pitocin · Obstetric Care
Medically indicated induction or reinforcement of labor, adjunctive management of incomplete or inevitable abortion, and control of postpartum bleeding under labeled conditions.
Authoritative label record
Status as of 2026-11-19. Regulations change. Check FDA.gov for current information.
WADA prohibited status: current list and contextKnown risks & open questions
Uterine overstimulation, water intoxication and cardiovascular effects are important risks.
Key sources
Indication-specific regulatory sources and editorial screen checked November 19, 2026. This is not an exhaustive systematic review; consult current labels.
Related compounds
- Gonadorelin
Same scientific class · A 10-amino-acid chain. · Evidence not yet assessed
- Human chorionic gonadotropin
Same scientific class · A protein or peptide identity whose molecular form must be specified. · FDA-approved for specific indications
- Kisspeptin
Same scientific class · A protein or peptide identity whose molecular form must be specified. · Early human trials